Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Transplant-ineligible myeloma: Daratumumab added to VCD deepens haematological response, improves PFS
Addition of daratumumab to the bortezomib, cyclophosphamide, and dexamethasone (VCD) regimen provides deeper haematological responses and improves progression-free survival (PFS) in patients with newly diagnosed myeloma who are not eligible for autologous stem cell transplantation (ASCT), according to the results of the AMaRC 03-16 phase II study.
Transplant-ineligible myeloma: Daratumumab added to VCD deepens haematological response, improves PFS
20 Aug 2024
Chemo plus atezolizumab improves survival while preserving life quality in advanced EC
Treatment with carboplatin-paclitaxel (CP) plus atezolizumab results in better quality-adjusted survival in patients with advanced or recurrent endometrial cancer (EC) as compared with CP alone, according to a post hoc analysis of the AtTEnd/ENGOT-EN7 trial.
Chemo plus atezolizumab improves survival while preserving life quality in advanced EC
19 Aug 2024
Navitoclax–ruxolitinib combo doubles spleen response rates in myelofibrosis
In untreated myelofibrosis, using navitoclax in combination with ruxolitinib appears to result in a twofold increase in the number of patients experiencing spleen volume shrinkage, regardless of prognosis, according to updated data from the phase III TRANSFORM-1 trial.
Navitoclax–ruxolitinib combo doubles spleen response rates in myelofibrosis
17 Aug 2024
AI improves physician accuracy in identifying prostate cancer extent
Use of artificial intelligence (AI)-assisted cancer contours helps minimize underestimation of the extent of prostate cancer, thereby improving the physician’s ability in terms of contouring accuracy and negative margin rate, a study has shown.
